BioNexus Gene Lab Cash Flow Statement 2018-2024 | BGLC

Fifteen years of historical annual cash flow statements for BioNexus Gene Lab (BGLC).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-2.63$-0.36$0.75$1.09$-0.25$0.03
$0.11$0.11$0.11$0.10$0.05$0.04
$1.10$-0.03$0.01$-0.75$0$0
$1.21$0.07$0.12$-0.64$0.05$0.04
$0.65$0.54$0.58$0.41$0.01$0.11
$-0.16$0.54$-0.35$0.15$0.01$0.02
$-0.38$-0.12$-1.18$-0.52$-0.03$-0.46
$0.01$-0.13$0.08$0.07$-0.01$0
$0.12$0.83$-0.86$0.10$-0.02$-0.34
$-1.30$0.55$0.01$0.55$-0.22$-0.27
$-0.15$-0.05$0.00$1.05$-0.01$-0.04
$0$0$0$0$0$0
$0$0$0$0.35$0$0
$0$0$0$0$0$0
$-0.29$-0.51$-0.51$-0.08$0$-0.01
$-0.29$-0.51$-0.51$-0.08$0$-0.01
$0.06$0.12$0.02$0.01$0$0
$-0.38$-0.45$-0.49$1.32$-0.01$-0.05
$0$-0.03$-0.03$0.00$-0.02$0
$0$0$0$0$0$0
$0$-0.03$-0.03$0.00$-0.02$0
$5.75$0.15$0$0$-0.16$0.74
$5.75$0.15$0$0$-0.16$0.74
$0$0$0$0$0$0
$0.00$-0.01$0.00$0$0.00$0.00
$5.75$0.11$-0.03$0.00$-0.18$0.74
$3.81$-0.01$-0.66$1.93$-0.40$0.42
$0.51$0$0$0$0$0
$0$0$0$0$0$0